Down 84% From Its High, Is NuScale Power a Bargain Hiding in Plain Sight?

NuScale Power shares have fallen ~84% from an ~$57 all-time high to under $10, reflecting investor skepticism despite progress toward commercialization. A 6GW potential TVA project with ENTRA1 remains nonbinding (no definitive PPA yet), with NuScale having already paid about $507M toward the first milestone and facing potentially another ~$1.2B if a binding PPA for up to 72 modules is signed. Near-term value is therefore highly speculative until the nonbinding arrangement converts into binding revenue.

Analysis

The market is likely mispricing the distinction between a headline-sized project and equity value creation. For SMR, a binding contract would be a sentiment catalyst, but the real question is how much of the economics accrue to the company versus the developer/partner stack, and how much cash gets burned upfront before any recurring revenue exists. That structure can create a classic “good news, weak P&L” outcome: the stock rerates on deal headlines while dilution and milestone obligations cap per-share upside.

The cleaner beneficiaries, if this progresses, are the broader nuclear supply-chain proxies rather than the developer itself. A TVA commitment would validate utility appetite for new baseload capacity, supporting engineers, EPC contractors, and fuel-cycle names over a 6-18 month horizon, while SMR remains exposed to financing and execution risk. In the next 1-3 months, expect headline-driven volatility rather than durable fundamental revision.

Contrarian view: the consensus may be underestimating how hard it is to turn a nonbinding framework into a financeable project with acceptable economics for a regulated buyer. The stock can still squeeze on contract news, but absent clarity on module pricing, financing, and milestone burden, this is still a speculation trade, not a value case. The thesis is falsified if a binding PPA is signed with limited incremental cash outlay and a credible funding plan, especially if management shows a path to positive operating cash flow without repeated capital raises.

Key Decisions for Investors

• Do not chase SMR on rumor-driven strength; wait for a binding PPA and disclosure on financing/milestone terms before taking a long. Horizon: 1-3 months. Falsifier: signed contract plus limited incremental capital need.
• If SMR spikes 15%+ on contract headlines, consider a tactical short via puts or a small fade trade. Risk/reward favors downside if the market is pricing in revenue that still may not accrue to equity holders.
• Pair trade: long URA, short SMR on any deal-driven pop to express nuclear adoption without single-name financing risk. Horizon: 3-12 months. This captures sector validation while avoiding developer dilution.
• Set an alert for any 8-K/press release that quantifies module pricing or milestone funding; if SMR can show a credible cash runway post-deal, cover shorts immediately. Otherwise the stock remains vulnerable to another de-rating.